Ironwood Pharmaceuticals (IRWD) Current Assets (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Current Assets across 17 years of filings, most recently posting $332.3 million for Q1 2026.

• Current Assets for Q1 2026 came in at $332.3 million, up 106.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $332.3 million (up 106.93% YoY), and the FY2025 annual result was $274.2 million, up 50.34% from the prior year.
• Current Assets came in at $332.3 million for Q1 2026 at Ironwood Pharmaceuticals, up from $274.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $866.4 million in Q1 2023 to a low of $160.6 million in Q1 2025.
• The 5-year median for Current Assets is $273.8 million (2025), against an average of $379.9 million.
• Across the five-year window, Current Assets slumped 75.97% in 2024 and jumped 106.93% in 2026, its largest moves.
• Ironwood Pharmaceuticals' Current Assets stood at $780.6 million in 2022, then sank by 70.12% to $233.3 million in 2023, then retreated by 21.83% to $182.4 million in 2024, then jumped by 50.34% to $274.2 million in 2025, then increased by 21.2% to $332.3 million in 2026.
• The last three Current Assets figures came in at $332.3 million (Q1 2026), $274.2 million (Q4 2025), and $273.8 million (Q3 2025), per Business Quant data.